Monthly Archives: May 2017
Why Does Immunotherapy Work in Some Patients but not in Others?
April 21, 2017 (Medical News Today)
André Veillette and a team of researchers at the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical...
Advances in Treating Sarcoma with Immunotherapy
January 19, 2017 (Discovery Medicine)
Sarcomas are rare and aggressive malignancies of bone and soft tissue affecting all ages of patients that are usually incurable...
CAR-T Cell Therapy HCP Guide – Mechanism of Action
CAR T-Cell Therapy: How It Works
Chimeric antigen receptor (CAR) T-cell therapy is an investigational form of immunotherapy -- in fact, the first gene therapy...
VIDEO: Dr. Steven Rosenberg on saving lives with Car T Therapy
December 17, 2015 (Leukemia & Lymphoma Society)
Dr. Steven Rosenberg explains why immunotherapies provides the best clues for cancer treatments for patients who can’t be...
StatPearls Question of the Week #2
What is the most common adverse effect of chimeric antigen receptor therapy (CAR-T)?
A. Reactivation of tuberculosis
B. Stevens-Johnson syndrome
C. Cytokine release...
Implanted scaffold with T cells rapidly shrinks tumors
April 26, 2017 (Medical News Today)
Cellular therapy hasn't had much success in fighting solid tumors, partly because it's been difficult to deliver anti-cancer T...
VIDEO: CAR-T Cell Therapies for CLL: How are the various techniques different?
November 13, 2015 (ImedexCME)
ImedexCME thorough video on the differences in CAR-T techniques.
Nanovaccine shows potential as immunotherapy for cancer
April 25, 2017 (Medical News Today)
The researchers call their approach "minimalist nanovaccine." It is a simple mixture of the tumor antigen (molecules that uniquely...
